Spotlight

UCL cancer immunotherapy company, Autolus, launches with £30m investment

A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.

Find out more



follow us on twitter


Archive of Events

<< 2012 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 2014 >>

Academic Enterprise Awards 2013

Start: Jun 4, 2013 9:00:00 AM

ACES 2013
The ACES - Academic Enterprise Awards - are the only pan-European awards for spin-out companies emerged from European universities and public research centres. The ACES programme is presented by the Science|Business Innovation Board.
<< 2012 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 2014 >>